Related Experiment Video
Updated: Feb 12, 2026

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
How to Diagnose and Treat Breast Implant-Associated Anaplastic Large Cell Lymphoma
Mark W Clemens1,2, Garry S Brody1,2, Raman C Mahabir1,2
1Houston, Texas; Los Angeles, Calif.; and Scottsdale, Ariz.
Insights
This article details diagnosing and treating breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). It covers diagnostic criteria, patient evaluation, surgical options, and adjuvant therapies for BIA-ALCL.
Area of Science:
- Oncology
- Plastic Surgery
- Pathology
Background:
- Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare malignancy.
- Early diagnosis and appropriate management are crucial for patient outcomes.
Purpose of the Study:
- To outline the diagnostic criteria for BIA-ALCL.
- To guide the evaluation and treatment of patients with suspected BIA-ALCL.
- To discuss staging, treatment outcomes, and prognosis.
Main Methods:
- Review of diagnostic criteria for BIA-ALCL.
- Description of patient evaluation, including imaging, laboratory tests, and pathology.
- Outline of surgical treatment strategies.
- Discussion of indications for systemic chemotherapy and radiation therapy.
Main Results:
- Diagnostic criteria for BIA-ALCL are established.
- A comprehensive approach to patient evaluation is presented.
- Treatment modalities, including surgery and adjuvant therapies, are detailed.
- Prognosis is linked to disease stage.
Conclusions:
- Accurate diagnosis and staging are essential for effective BIA-ALCL management.
- Multidisciplinary treatment, including surgery and potentially systemic therapies, improves outcomes.
- Understanding prognosis based on stage aids in patient counseling and treatment planning.
Learning Objectives:
After reading this article, the participant should be able to: 1. Describe the diagnostic criteria for breast implant-associated (BIA) anaplastic large cell lymphoma (ALCL). 2. Appropriately evaluate a patient with suspected BIA-ALCL, including appropriate imaging, laboratory tests, and pathologic evaluation. 3. Understand the operative treatment of BIA-ALCL, and indications for systemic chemotherapy and/or radiation therapy in advanced disease. 4. Understand treatment outcomes and prognosis based on stage of disease.
Summary:
The goal of this continuing medical education module is to present the assessment of a patient with suspected breast implant-associated anaplastic large cell lymphoma, the evaluation and diagnosis, the preoperative oncologic workup, the formation and execution of a surgical treatment plan, and the inclusion of adjunct treatments when indicated. In addition, staging and disease progression for treatment of breast implant-associated anaplastic large cell lymphoma are discussed.
Related Concept Videos
Diagnosing Acidosis and Alkalosis
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2 and...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Induced Pluripotent Stem Cells
What are Cells?
Basic Characteristics of Cells
A living cell has a plasma membrane, a bilayer of lipids that separates the aqueous solution inside the cell called the cytoplasm from the outside environment.
Furthermore, a living cell possesses genetic information...
What is Cell Signaling?

